[Abstract] [Full Text PDF] (in Japanese / 2195KB) [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 90(5): 686-694, 1989


Original article

PERIOPERATIVE AJUVANT CHEMOTHERAPY FOR TREATMENT OF LYMPH NODE METASTASES OF COLORECTAL CANCER

Department of Surgery, Sendai National Hospital, Sendai, Japan

Seiichi Kojima

This study was undertaken to evaluate the effectiveness of perioperative ajuvant chemotherapy for the treatment and prevention of lymph node metastasis of coloredtal cancer. Namely, ten thousand unit (U) of NCS, the high molecular weight anti-tumor agent, was injected into the subserosa of the colon (n= 51), the tumor-feeding arteries(n=6), or the peripheral veins (n=6) immediately after laparotomy, and tissue concentration of NCS in the regional lymph nodes and intestinal wall was measured.
After the injection of NCS into the subserosa, the regional lymph nodes showed higher concentration of 4.55-6.34U/g regardless of metastasis. Concentratins in the lymph nodes after NCS into the tumorfeeding arteries showed similar high level as those after the subserosal injection in Group l lymph nodes (paracolic and epicolic nodes), but not in Group 2 lymph nodes(intermediate nodes). The injection of NCS into the peripheral veins demonstrated a wide range of 0.01-5.0U/g, half of them being not effective concentratins.
Perioperative injectin of NCS into the subserosa in the colorectal cancer was technioally simple and safe and a large amount of the agent was taken into the regional lymph nodes. Therefore, this strategy may be a rational treatment for slight or jumping metastases in the lymph nodes.


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.